Petros Pharmaceuticals, Inc. PTPI
0.00 USD 0.00 (+26.92%)
As ofNov 17, 2026, 1:22 PM EST
0.0026 Day range 0.0033
0.002 52-week range 0.016
- YTD
- -58.75%
- 1 year
- -80.59%
PTPI revenue history
Revenue is income from the company’s ordinary business activities.
5,112,043 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 5,112,043 | -710,345 | -12.20% |
| FY 2023 | 2023-12-31 | 5,822,388 | -169,666 | -2.83% |
| FY 2022 | 2022-12-31 | 5,992,054 | -1,819,210 | -23.29% |
| FY 2021 | 2021-12-31 | 7,811,264 | -1,748,205 | -18.29% |
| FY 2020 | 2020-12-31 | 9,559,469 | -6,017,697 | -38.63% |
| FY 2019 | 2019-12-31 | 15,577,166 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-08-15T15:35:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
